Ammonium formate → HCID 89456771, compound

HRID 1915938Notes

Reaction equation

HRID 1915938 reaction equation
[F:1][C:2]([F:25])([F:24])[C:3]([NH:5][C:6]1([CH3:23])[CH:12]([OH:13])[CH2:11][CH2:10][N:9]([C:14]2[N:18]([CH3:19])[N:17]=[CH:16][C:15]=2[N+:20]([O-])=O)[CH2:8][CH2:7]1)=[O:4].C([O-])=O.[NH4+]>CO.[Pd]>[NH2:20][C:15]1[CH:16]=[N:17][N:18]([CH3:19])[C:14]=1[N:9]1[CH2:10][CH2:11][CH:12]([OH:13])[C:6]([NH:5][C:3](=[O:4])[C:2]([F:25])([F:24])[F:1])([CH3:23])[CH2:7][CH2:8]1

Participants

5

Conditions

Temperature
65 °C

Procedure

To a solution of 2,2,2-trifluoro-N-(5-hydroxy-4-methyl-1-(1-methyl-4-nitro-1H-pyrazol-5-yl)azepan-4-yl)acetamide (200 mg, 0.55 mmol) and ammonium formate (700 mg, 2.74 mmol) in MeOH (10 mL) under nitrogen was added 10% palladium on carbon (50 mg, 0.13 mmol). The mixture was heated at 65° C. for 2 hr before being cooled to room temperature, filtered and concentrated under reduced pressure. The residue was partitioned between water (10 mL) and DCM (50 mL). The organic layer was separated, passed through a phase separation cartridge and concentrated under reduced pressure to give N-(1-(4-amino-1-methyl-1H-pyrazol-5-yl)-5-hydroxy-4-methylazepan-4-yl)-2,2,2-trifluoroacetamide as a red gum (140 mg). A solution of PyBOP (330 mg, 0.62 mmol) and 5-(tert-butoxycarbonylamino)-2-(2,6-difluorophenyl)thiazole-4-carboxylic acid (160 mg, 0.45 mmol) in DCM (3 mL) was stirred at room temperature for 30 min. A solution of N-(1-(4-amino-1-methyl-1H-pyrazol-5-yl)-5-hydroxy-4-methylazepan-4-yl)-2,2,2-trifluoroacetamide (140 mg, 0.41 mmol) and DIPEA (140 μL, 0.83 mmol) in DCM (2 mL) was added and the mixture was stirred at room temperature for 18 hr. Additional DCM (50 mL) was added and the mixture washed with water (20 mL). The organic layer was passed through a phase separation cartridge and concentrated under reduced pressure. The residue was dissolved in a mixture of THF (2 mL), MeOH (2 mL) and water (1 mL) and potassium carbonate (200 mg, 1.44 mmol) was added. The reaction mixture was heated at 60° C. for 18 hr, cooled to room temperature, filtered and concentrated under reduced pressure. The residue was then dissolved in DCM (3 mL) and trifluoroacetic acid (1 mL) added. The mixture was stirred at room temperature for 2 hr, concentrated under reduced pressure and purified via preparative HPLC to give 424 as the monoformate salt as a white solid (5 mg, 2% over three steps). 1H NMR (400 MHz, d4-MeOD) δ 8.56 (s, 1H), 7.57 (s, 1H), 7.53-7.44 (m, 1H), 7.15 (t, J=8.8 Hz, 2H), 3.86-3.72 (m, 5H), 3.45-3.35 (m, 2H), 3.26-3.14 (m, 1H), 2.15-1.90 (m, 4H), 1.46 (s, 3H). LCMS (ES+) m/z 478 (M+1)

Workup

  1. temperaturebefore being cooled to room temperature
  2. filtrationfiltered
  3. concentrationconcentrated under reduced pressure
  4. customThe residue was partitioned between water (10 mL) and DCM (50 mL)
  5. customThe organic layer was separated
  6. custompassed through a phase separation cartridge
  7. concentrationconcentrated under reduced pressure

Sources & evidence

ORD record
ord-7ed0fe34f1a5438a80c7edfba979fe35
Source dataset
uspto-grants-2013_12
Patent number
US08614206B2

Reaction notes

Loading…